Drug-induced osteoporosis with pathological fracture

OSTPOPATFRACTURE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M80.4# Cause of death: ICD-10 — M80.4# 2 out of 7 registries used, show all original rules.	673
4. Check minimum number of events None	673
5. Include endpoints None	673
6. Filter based on genotype QC (FinnGen only)	598

Control definitions (FinnGen only)

Control exclude: OSTEOPOROSIS_FRACTURE_FG

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M80
Name in latin: Osteoporosis e medicamento cum fractura pathologica

NAME	OSTPOPATFRACTURE
CONTROL_EXCLUDE	OSTEOPOROSIS_FRACTURE_FG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M804
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M804
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced osteoporosis with pathological fracture based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2573	1758	796
Only index persons	2250	1568	682
Unadjusted period prevalence (%)
Whole population	0.04	0.05	0.02
Only index persons	0.05	0.06	0.03
Median age at first event (years)
Whole population	70.33	71.59	67.62
Only index persons	70.23	71.36	67.63

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	598	423	175
Unadjusted period prevalence (%)	0.13	0.15	0.08
Median age at first event (years)	69.53	69.20	70.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
615: Matched controls
6150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

+∞

307.7

615

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

18.5

287.9

298

M05BX04

ATC

denosumab; parenteral

17.3

263.3

274

273

318

Kela drug reimbursment

Teriparatide

520.1

245.4

229

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

32.3

225.5

154

H05AA02

ATC

teriparatide; parenteral

534.3

224.0

210

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

24.8

205.5

156

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

46.3

199.1

120

M05BA04

ATC

alendronic acid; oral

10.9

186.7

274

424

L04AX01

ATC

azathioprine; systemic

18.6

183.5

161

115

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

10.4

179.6

271

432

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

10.2

176.1

269

434

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

16.0

165.1

543

1974

L04AX03

ATC

methotrexate; systemic

9.6

154.8

235

371

L95

ICPC

Osteoporosis

12.3

147.3

168

182

M81.9

ICD-10 Finland

Osteoporosis, unspecified

11.6

145.1

174

202

P01BA02

ATC

hydroxychloroquine; oral

8.7

129.2

205

335

H02AB06

ATC

prednisolone; systemic

11.3

120.2

539

2373

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

9.6

119.6

164

224

H02AB09

ATC

hydrocortisone; systemic

17.3

117.0

102

L01BA01

ATC

methotrexate; systemic

13.7

115.7

117

104

L04AA06

ATC

mycophenolic acid; systemic

26.1

115.0

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

9.2

109.8

154

215

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

11.8

106.0

118

121

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

8.3

102.3

158

246

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.6

93.1

255

691

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

9.0

92.1

127

172

L04AA13

ATC

[U] leflunomide

14.1

90.9

H02AB07

ATC

prednisone; oral

5.8

90.5

224

554

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

11.1

89.1

102

108

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.1

85.8

282

880

L88

ICPC

Rheumatoid/seropositive arthritis

9.8

84.8

107

129

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

48.3

83.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

14.1

77.4

M05BA07

ATC

risedronic acid; oral

9.3

74.1

122

J01MA12

ATC

levofloxacin; systemic

4.7

72.6

246

771

M81.4

ICD-10 Finland

Drug-induced osteoporosis

109.8

71.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.3

70.1

307

1158

N02AA05

ATC

oxycodone; systemic

4.4

68.4

260

882

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.9

65.2

478

2556

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.0

64.2

171

438

H02AB04

ATC

methylprednisolone; systemic

4.6

64.0

200

582

R50.9

ICD-10 Finland

Fever, unspecified

4.6

63.7

200

584

A07EC01

ATC

sulfasalazine; oral, rectal

6.0

63.5

130

264

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

9.2

61.2

ZX120

NOMESCO Finland

Intravenous

5.1

61.2

154

375

L04AD01

ATC

ciclosporin; systemic

15.0

60.3

C03CA01

ATC

furosemide; systemic

3.9

60.2

349

1557

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

11.8

60.2

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

12.2

59.7

L04AB01

ATC

etanercept; parenteral

19.0

57.3

127

Kela drug reimbursment

Transplant complication

19.7

55.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

7.6

54.8

123

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

8.8

54.4

N02AX02

ATC

tramadol; systemic, rectal

3.7

53.6

406

2104

NF1AA

NOMESCO Finland

Hip X-ray examination

4.6

53.5

153

410

L04AA01

ATC

[U] ciclosporin

19.5

53.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.9

51.8

207

708

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.5

51.6

322

1468

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.5

50.6

336

1587

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.1

49.4

169

516

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.2

49.3

173

M05BB03

ATC

alendronic acid and colecalciferol; oral

8.9

49.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.0

48.9

121

287

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.3

48.5

155

450

S97

ICPC

Chronic ulcer skin

5.2

48.0

113

257

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

7.8

47.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.4

46.8

140

386

TPH04

NOMESCO Finland

Cathetrisation of vein

3.4

46.1

241

971

R03BB04

ATC

tiotropium bromide; inhalant

4.4

45.8

138

382

M01CB01

ATC

sodium aurothiomalate; parenteral

13.9

45.5

X59

ICD-10 Finland

Exposure to unspecified factor

3.6

45.1

207

767

SPAT1255

SPAT

Intravenous administration of medicine

5.4

44.9

212

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

8.0

44.9

L28

ICPC

Limited function/disability (L)

3.4

44.8

239

972

M81.8

ICD-10 Finland

Other osteoporosis

14.0

44.7

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.3

44.5

136

380

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

104.0

44.5

L04AB04

ATC

adalimumab; parenteral

11.2

44.3

TGC00

NOMESCO Finland

Bronchial lavation

8.4

44.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.7

44.0

116

289

M35.3

ICD-10 Finland

Polymyalgia rheumatica

5.7

43.5

178

N03AX16

ATC

[U] pregabalin

3.3

43.3

247

1043

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

14.2

42.9

M54.5

ICD-10 Finland

Low back pain

3.1

42.8

336

1704

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.9

42.3

J01MA14

ATC

moxifloxacin; systemic

4.3

42.1

126

346

GD1AD

NOMESCO Finland

Thorax CT examination

4.9

41.5

101

235

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

7.4

41.1

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.4

40.9

184

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.6

40.9

169

581

M80

ICD-10 Finland

Osteoporosis with pathological fracture

17.1

40.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.8

40.1

151

487

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.3

40.0

121

334

J45.9

ICD-10 Finland

Asthma, unspecified

3.3

39.6

214

867

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.0

39.5

355

1915

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.3

38.7

115

313

J01MA02

ATC

ciprofloxacin; systemic

3.0

38.6

340

1806

A07AA02

ATC

nystatin; oral

4.8

38.3

224

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

37.9

208

848

SPAT1229

SPAT

Assessment of need for aid

4.3

37.7

113

309

J46

ICD-10 Finland

Status asthmaticus

8.0

37.5

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.2

36.9

111

304

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

10.0

36.6

A46

ICD-10 Finland

Erysipelas

3.4

36.3

162

581

SPAT1254

SPAT

Administration of medicine

3.4

36.2

166

605

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.7

36.0

138

448

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.8

36.0

131

411

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.5

35.5

150

A28

ICPC

Limited function/disability NOS

3.0

35.1

214

920

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.1

34.6

L03

ICPC

Low back symptom/complaint

2.8

34.5

273

1349

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.3

34.3

160

588

XG410

NOMESCO Finland

Flow-volume spirometry

6.0

34.2

117

E0000UV, ,

ATC

2.8

34.1

353

1999

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

10.6

33.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.9

33.9

117

353

A41.9

ICD-10 Finland

Sepsis, unspecified

6.4

33.7

101

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

6.4

33.5

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.9

33.4

116

A07AA09

ATC

vancomycin; oral

11.2

33.4

J47

ICD-10 Finland

Bronchiectasis

7.7

32.6

J45.8

ICD-10 Finland

Mixed asthma

6.5

32.4

J45.1

ICD-10 Finland

Nonallergic asthma

4.2

32.2

265

J01FF01

ATC

clindamycin; systemic

2.8

32.1

248

1201

S22.3

ICD-10 Finland

Fracture of rib

4.3

31.7

244

SPAT1216

SPAT

Assessment of functional ability

3.0

31.6

179

733

D64.9

ICD-10 Finland

Anaemia, unspecified

3.5

31.2

127

426

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.8

31.0

106

317

B01AB05

ATC

enoxaparin; parenteral

2.7

30.9

296

1589

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

4.0

30.9

273

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

8.7

30.7

UJF32

NOMESCO Finland

Coloscopy

2.7

30.7

253

1261

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

11.6

30.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.8

30.4

107

326

L76

ICPC

Fracture: other

6.0

30.3

101

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

8.2

30.1

R03DA04

ATC

theophylline; systemic, rectal

4.8

30.1

168

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

10.8

30.0

A05AA02

ATC

ursodeoxycholic acid; oral

10.0

30.0

N03AX12

ATC

[U] gabapentin; oral

3.0

29.3

172

715

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.9

29.2

151

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

5.2

29.2

131

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

7.3

29.2

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.9

29.2

175

736

WZC00

NOMESCO Finland

Treatment plan or consultation

2.6

29.1

304

1689

ZXD05

NOMESCO Finland

Urgent procedure

2.6

28.7

243

1219

A02BC02

ATC

pantoprazole; systemic

3.3

28.7

515

3729

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.7

28.4

233

1150

X58

ICD-10 Finland

Exposure to other specified factors

3.1

28.3

141

533

M05BA06

ATC

ibandronic acid; systemic

6.3

28.2

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

9.9

28.2

R03BA05

ATC

fluticasone; inhalant

2.9

28.2

176

755

J96.1

ICD-10 Finland

Chronic respiratory failure

7.7

27.9

I50.9

ICD-10 Finland

Heart failure, unspecified

3.0

27.8

155

625

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.9

27.6

161

665

N02AJ06

ATC

codeine and paracetamol; systemic

2.5

27.4

345

2073

JN4AD

NOMESCO Finland

Body CT examination

3.2

27.3

129

472

NH3EA

NOMESCO Finland

Feet X-ray examination with load

7.9

27.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.6

27.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.0

27.0

142

553

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

27.0

135

511

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

7.2

26.2

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.8

26.1

144

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.2

26.0

116

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.1

25.8

126

469

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

10.4

25.8

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.9

25.6

238

R06.0

ICD-10 Finland

Dyspnoea

2.5

25.4

254

1361

NF3AA

NOMESCO Finland

Femur X-ray examination

5.6

25.1

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.7

24.7

138

WZC30

NOMESCO Finland

Teaching

2.7

24.6

162

709

W19

ICD-10 Finland

Unspecified fall

3.3

24.5

107

372

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.2

24.3

179

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.2

24.3

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.0

24.1

199

SPAT1262

SPAT

Handing over of treatment supplies

2.7

24.1

161

709

M13.9

ICD-10 Finland

Arthritis, unspecified

3.7

23.9

254

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

23.9

163

725

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.6

23.8

AA1AD

NOMESCO Finland

CT of head and brain

2.4

23.7

261

1452

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

4.8

23.6

126

C03DA01

ATC

spironolactone; oral

2.9

23.5

134

542

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

4.3

23.5

161

A06AD11

ATC

lactulose; oral

2.7

23.4

151

652

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.1

23.4

113

417

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.9

23.4

XW000

NOMESCO Finland

Bone marrow biopsy

4.7

23.2

132

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.0

23.2

190

WX002

NOMESCO Finland

Sedation and analgesia

2.6

23.2

183

873

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

23.2

181

859

JN4BD

NOMESCO Finland

Extensive body CT

3.1

23.1

111

408

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

23.1

213

1092

WX892

NOMESCO Finland

Monitored bed care

3.6

22.8

257

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.2

22.6

161

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.3

22.6

325

2014

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.6

22.6

243

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.0

22.3

181

Z3226

NOMESCO Finland

Physiotherapist

2.6

22.3

168

782

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.3

22.2

373

2459

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

22.2

202

1027

Z2446

NOMESCO Finland

Social worker

3.7

21.8

223

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

21.8

335

2123

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

32.5

21.7

UJF30

NOMESCO Finland

Ileoscopy through colon

3.0

21.6

112

429

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.5

21.6

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.0

21.5

172

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

21.4

251

1419

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.7

21.2

116

WX882

NOMESCO Finland

High dependency care

5.6

21.2

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

4.8

20.9

109

TDM10

NOMESCO Finland

Puncture of maxillary antrum

4.9

20.9

105

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

20.8

363

2406

WW200

NOMESCO Finland

Immunization

6.1

20.8

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.1

20.8

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

9.0

20.8

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.1

20.8

344

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.5

20.7

127

SPAT1211

SPAT

Application of soft bandage

3.2

20.4

325

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

20.3

354

Z94.4

ICD-10 Finland

Liver transplant status

49.8

20.3

TQW40

NOMESCO Finland

Remowal of suture of skin

3.3

20.2

271

A02BC05

ATC

esomeprazole; systemic

2.2

20.2

320

2031

A07EA06

ATC

budesonide; oral, local oral

4.5

20.2

125

ZX108

NOMESCO Finland

Inhalation

19.6

20.1

R03AK08

ATC

formoterol and beclometasone; inhalant

4.1

20.0

148

R5110, ,

SPAT

2.9

20.0

105

404

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.5

20.0

150

693

R03AC12

ATC

salmeterol; inhalant

4.1

19.9

153

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

19.9

143

647

H26.3

ICD-10 Finland

Drug-induced cataract

17.1

19.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.7

19.8

192

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.4

19.6

164

796

R60.0

ICD-10 Finland

Localized oedema

2.6

19.5

132

580

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

5.6

19.2

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

19.1

110

444

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.1

19.1

320

TQW99

NOMESCO Finland

Other minor procedure on skin

3.7

19.0

192

NH1AD

NOMESCO Finland

Ankle and foot CT

6.0

19.0

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.9

19.0

163

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

5.0

19.0

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.8

18.9

178

R03BB01

ATC

ipratropium bromide; inhalant

4.2

18.9

136

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

3.6

18.9

193

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.1

18.9

302

1910

JJC00

NOMESCO Finland

Allogenic transplantation of liver

72.2

18.8

K50.9

ICD-10 Finland

Crohn disease, unspecified

7.9

18.8

WW500

NOMESCO Finland

Blood transfusion

4.2

18.8

132

N05CF01

ATC

zopiclone; oral

2.2

18.6

266

1607

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.8

18.6

175

R4120

NOMESCO Finland

Occupational therapy

3.4

18.6

236

J01DB01

ATC

cefalexin; oral

3.1

18.6

547

4434

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.7

18.6

116

488

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.4

18.6

226

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.2

18.5

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.5

18.5

211

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

18.4

137

628

SPAT1263

SPAT

Sampling

2.1

18.4

308

1975

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.2

18.4

R03DC03

ATC

montelukast; oral

2.5

18.4

145

683

B01AA03

ATC

warfarin; systemic

2.4

18.4

159

781

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

18.4

265

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.4

18.3

233

A07EC02

ATC

mesalazine; oral, rectal

3.9

18.3

153

R03AC02

ATC

salbutamol; inhalant

2.2

18.3

394

2777

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

5.6

18.3

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.9

18.2

R4110

NOMESCO Finland

Physiotherapy

2.2

18.2

230

1322

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.3

18.2

122

TQW80

NOMESCO Finland

Local dermatologic skincare

5.6

18.0

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.6

18.0

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.0

17.9

146

EBA10

NOMESCO Finland

Operative extraction of tooth

3.0

17.9

320

L04AD02

ATC

tacrolimus; systemic

20.8

17.9

N06AX21

ATC

duloxetine; oral

2.7

17.9

115

491

EBA15

NOMESCO Finland

Extraction of multiple teeth

4.6

17.8

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

6.4

17.8

Z3231

NOMESCO Finland

Registered nurse

2.2

17.8

214

1205

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.3

17.8

243

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.4

17.8

111

R03AC13

ATC

formoterol; inhalant

3.6

17.7

191

R52.2

ICD-10 Finland

Other chronic pain

4.0

17.7

138

M05BA01

ATC

etidronic acid; systemic

16.2

17.6

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.6

17.6

S18

ICPC

Laceration/cut

2.1

17.6

357

2447

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

17.6

17.5

XF600

NOMESCO Finland

Bloodpressure measurement

3.3

17.5

229

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

17.5

117

509

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

14.4

17.4

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.2

17.4

217

1237

L29

ICPC

Musculoskeletal sympt/complt other

2.9

17.3

355

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

6.6

17.2

M54.6

ICD-10 Finland

Pain in thoracic spine

3.1

17.2

275

R60.9

ICD-10 Finland

Oedema, unspecified

3.4

17.2

205

TK800

NOMESCO Finland

Hemodialysis

6.8

17.2

ZXE00

NOMESCO Finland

One hour or less

2.1

17.1

277

1740

XKD00

NOMESCO Finland

Uroflowmetry

2.7

17.1

106

443

K50.0

ICD-10 Finland

Crohn disease of small intestine

7.4

17.1

M48.0

ICD-10 Finland

Spinal stenosis

2.5

16.8

130

605

SAA03

NOMESCO Finland

Extended examination of mouth

2.1

16.7

272

1708

R52.9

ICD-10 Finland

Pain, unspecified

2.7

16.7

101

417

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

13.9

16.6

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.3

16.6

108

A01

ICPC

Pain general/multiple sites

2.6

16.6

109

469

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.0

16.5

131

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.6

16.4

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

5.2

16.4

K83.0

ICD-10 Finland

Cholangitis

7.0

16.2

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

7.0

16.2

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

6.2

16.2

R03AC03

ATC

terbutaline; inhalant

2.5

16.1

118

534

C07AB07

ATC

bisoprolol; oral

2.0

16.0

373

2650

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

12.7

16.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.0

15.8

121

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.0

15.8

121

A04

ICPC

Weakness/tiredness general

2.4

15.7

132

636

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.1

15.7

113

J02AC01

ATC

fluconazole; systemic

2.0

15.6

285

1852

J01FA06

ATC

roxithromycin; oral

2.0

15.6

293

1923

R02

ICPC

Shortness of breath/dyspnoea

2.4

15.6

125

589

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.0

15.6

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

5.9

15.5

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.4

15.5

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6.9

15.4

J05AB11

ATC

valaciclovir; oral

2.4

15.3

129

621

A02BA02

ATC

ranitidine; systemic

2.2

15.3

166

889

WX872

NOMESCO Finland

Intensive care

3.6

15.3

153

SAA04

NOMESCO Finland

Special examination of mouth

3.6

15.3

158

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

4.2

15.2

102

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

24.1

15.2

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.5

15.1

169

UJF92

NOMESCO Finland

Capsular endoscopy

5.6

15.1

N30.0

ICD-10 Finland

Acute cystitis

2.2

15.1

152

790

A08

ICPC

Swelling

3.0

15.0

256

R03BA01

ATC

beclometasone; inhalant

2.4

15.0

116

537

K50.8

ICD-10 Finland

Other Crohn disease

7.0

15.0

RD210, ,

NOMESCO Finland

7.0

15.0

R01AD08

ATC

fluticasone; nasal

2.1

14.9

200

1160

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.7

14.9

L02

ICPC

Back symptom/complaint

2.6

14.9

402

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.9

14.8

287

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.9

14.8

118

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

14.8

130

638

K08.3

ICD-10 Finland

Retained dental root

2.9

14.7

277

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

14.7

386

R11

ICD-10 Finland

Nausea and vomiting

2.7

14.6

355

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.7

14.6

133

M79.6

ICD-10 Finland

Pain in limb

1.9

14.6

330

2292

A01AB09

ATC

miconazole; local oral

2.7

14.6

362

B01AB04

ATC

dalteparin; parenteral

3.5

14.6

153

N03AX09

ATC

lamotrigine; oral

3.9

14.4

120

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

14.4

265

1715

M05BX03

ATC

strontium ranelate; oral

17.5

14.4

UKC02

NOMESCO Finland

Cystoscopy

2.3

14.3

123

596

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.0

14.3

246

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

14.2

142

733

R28

ICPC

Limited function/disability (R)

6.6

14.2

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.2

14.2

203

E000003, ,

ATC

3.9

14.1

117

A07DA03

ATC

loperamide; oral

4.3

14.1

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

11.3

14.1

TKC20

NOMESCO Finland

Catheterisation of bladder

3.1

14.1

220

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.3

14.1

172

M70.2

ICD-10 Finland

Olecranon bursitis

4.5

14.0

R81

ICPC

Pneumonia

4.0

13.9

109

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.6

13.8

143

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.6

13.7

139

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

12.4

13.7

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

76.9

13.6

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.6

13.6

140

NHQ40

NOMESCO Finland

Amputation of toe

6.2

13.5

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.6

13.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

13.4

308

ZXA10

NOMESCO Finland

Bilateral

2.1

13.3

158

870

SPAT1325

SPAT

Vaccination

1.9

13.3

254

1653

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

5.1

13.2

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.8

13.2

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.9

13.2

240

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

13.2

254

1657

N06AA09

ATC

amitriptyline; systemic

2.5

13.2

406

R4110, ,

SPAT

2.2

13.1

123

617

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

5.4

13.1

A41.8

ICD-10 Finland

Other specified sepsis

5.2

13.0

S92.3

ICD-10 Finland

Fracture of metatarsal bone

3.8

13.0

110

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

12.9

296

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.5

12.9

ZZA00

NOMESCO Finland

Split skin graft

4.4

12.9

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

14.4

12.8

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

12.8

334

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.3

12.8

166

N02BF01

ATC

gabapentin; oral

2.4

12.8

457

L03.9

ICD-10 Finland

Cellulitis, unspecified

5.6

12.7

N05BA04

ATC

oxazepam; oral

2.0

12.6

194

1170

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

4.4

12.6

SPAT1234

SPAT

Support of social functional capacity

3.1

12.6

184

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

12.6

110

536

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

6.4

12.5

NA2AD

NOMESCO Finland

Thoracic spine CT examination

13.5

12.5

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.1

12.5

140

753

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.9

12.5

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

12.4

148

816

ZXA00

NOMESCO Finland

Right side

1.9

12.3

211

1319

C10AC01

ATC

colestyramine; oral

4.2

12.3

R03DC01

ATC

zafirlukast; oral

5.1

12.3

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

6.2

12.2

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.3

12.2

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

12.1

239

5BA08, ,

NOMESCO Finland

11.4

12.1

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

9.6

12.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.8

12.1

106

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.3

12.1

151

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.3

12.0

146

49300

ICD-8 Finland

Asthma, bronchiale

4.8

12.0

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.8

11.9

102

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.4

11.9

418

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.4

11.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.9

11.7

A02BC03

ATC

lansoprazole; oral

1.9

11.7

222

1428

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.4

11.7

133

PAW37

NOMESCO Finland

Biopsy of temporal artery

12.9

11.7

XQ800

NOMESCO Finland

Prick test

2.8

11.7

238

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

66.2

11.6

K05.18

ICD-10 Finland

Chronic gingivitis

2.8

11.6

227

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

11.6

146

818

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

11.6

168

989

WVA20, ,

SPAT

3.5

11.6

119

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

3.8

11.6

QDB10, ,

SPAT

3.8

11.5

100

N02AC04

ATC

dextropropoxyphene; oral

3.6

11.4

115

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

12.1

11.4

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.8

11.4

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

15.4

11.4

K50.1

ICD-10 Finland

Crohn disease of large intestine

9.1

11.3

B80

ICPC

Iron deficiency anaemia

4.5

11.3

L17

ICPC

Foot/toe symptom/complaint

1.8

11.3

232

1527

R03BA02

ATC

budesonide; inhalant

2.0

11.3

141

787

H25.8

ICD-10 Finland

Other senile cataract

2.2

11.3

103

510

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

11.2

108

546

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.3

11.2

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

25.6

11.2

WX212

NOMESCO Finland

Femoral plexus blockade

4.1

11.1

Z01.2

ICD-10 Finland

Dental examination

1.8

11.1

295

2093

WX202

NOMESCO Finland

Supraclavicular plexus blockade

5.9

11.1

WX320

NOMESCO Finland

Spinalanesthesy

1.9

11.1

191

1189

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

4.0

11.1

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.6

11.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

11.0

358

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.0

11.0

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

5.0

11.0

A02BC01

ATC

omeprazole; systemic

1.9

11.0

200

1265

A03CA02

ATC

clidinium and psycholeptics; oral

2.8

11.0

216

WX725

NOMESCO Finland

Noninvasive ventilation

2.9

11.0

193

R53

ICD-10 Finland

Malaise and fatigue

1.9

11.0

187

1158

N06AX16

ATC

venlafaxine; oral

2.2

11.0

105

529

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

44.2

11.0

A06AH03

ATC

naloxegol; oral

5.5

10.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

10.9

215

1395

R06AE07

ATC

cetirizine; oral

1.8

10.9

288

2039

SPAT1172

SPAT

Guidance concerning hydration

4.4

10.9

K02.1

ICD-10 Finland

Caries of dentine

1.8

10.9

356

2680

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

10.8

WX213

NOMESCO Finland

Lower leg blockade

10.8

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

10.8

A07EA02

ATC

hydrocortisone; rectal

5.0

10.8

M54.8

ICD-10 Finland

Other dorsalgia

3.2

10.8

140

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

28.6

10.8

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

10.7

125

679

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

21.9

10.7

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

10.7

311

Z2221

NOMESCO Finland

Medical doctor

1.9

10.7

185

1151

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.4

10.7

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

61.1

10.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

10.7

136

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

10.6

238

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

11.5

10.6

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

10.6

405

3178

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

10.6

418

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

10.6

100

501

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.9

10.6

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.8

10.6

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

4.2

10.5

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.7

10.4

228

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

10.4

115

612

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.4

10.4

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

8.4

10.4

WZA90

NOMESCO Finland

Other medical or dental certificate

1.9

10.4

166

1005

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.3

10.3

128

L74

ICPC

Fracture: hand/foot bone

4.7

10.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.8

10.3

200

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.1

10.3

155

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

10.2

150

882

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

10.2

112

594

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

10.2

172

1058

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

10.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

10.2

291

2094

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

3.4

10.1

109

L01BB02

ATC

mercaptopurine; oral

8.7

10.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

10.1

244

S72.3

ICD-10 Finland

Fracture of shaft of femur

9.4

10.1

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.7

10.1

SPAT1167

SPAT

Insertion of urinary catheter

3.7

10.1

L04AA24

ATC

abatacept; parenteral

14.9

10.0

J45

ICD-10 Finland

Asthma

2.3

10.0

381

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

9.9

257

1794

J05AB01

ATC

aciclovir; systemic

1.9

9.9

163

994

A11CC03

ATC

alfacalcidol; systemic

4.5

9.9

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

9.9

L04AA17

ATC

[U] adalimumab

26.5

9.8

B01AB10

ATC

tinzaparin; parenteral

2.2

9.8

459

S72.0

ICD-10 Finland

Fracture of neck of femur

3.1

9.8

143

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

9.7

261

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.5

9.7

102

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.1

9.6

505

E000006, ,

ATC

2.6

9.6

250

NB1AD

NOMESCO Finland

Shoulder CT examination

4.6

9.6

XG466

NOMESCO Finland

Sleep oxymetry

3.7

9.6

J20

ICD-10 Finland

Acute bronchitis

2.2

9.6

421

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.7

9.6

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

9.6

133

766

L86

ICPC

Back syndrome with radiating pain

2.6

9.6

232

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

9.5

209

TAB00

NOMESCO Finland

Lumbar puncture

3.0

9.5

146

R4190

NOMESCO Finland

Nutritional therapy

3.3

9.5

109

JJ5AT, ,

NOMESCO Finland

101.5

9.4

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

5.3

9.4

NDG30

NOMESCO Finland

Fusion of wrist, total

12.6

9.4

J01AA02

ATC

doxycycline; systemic

1.9

9.4

502

4274

B02.9

ICD-10 Finland

Zoster without complication

2.5

9.4

272

B01AF02

ATC

apixaban; oral

2.0

9.4

117

650

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

9.3

292

S72.2

ICD-10 Finland

Subtrochanteric fracture

9.7

9.3

L75

ICPC

Fracture: femur

7.5

9.3

K03.66

ICD-10 Finland

Tooth plaque

2.5

9.3

267

M54

ICD-10 Finland

Dorsalgia

2.1

9.3

455

A06AC51

ATC

ispaghula, combinations; oral

2.8

9.2

183

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

4.1

9.1

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

8.5

9.1

ZX140

NOMESCO Finland

Intra articular

9.2

9.1

J01FA15

ATC

telithromycin; oral

2.3

9.0

356

D07AC13

ATC

mometasone; topical

1.8

9.0

193

1270

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

18.9

9.0

SCA02

NOMESCO Finland

Preventive oral health care

2.3

9.0

317

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

8.9

440

3620

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

8.1

8.9

XCK00

NOMESCO Finland

Perimetry

2.6

8.9

216

N28

ICPC

Limited function/disability (N)

4.8

8.9

X57

ICD-10 Finland

Unspecified privation

4.1

8.9

N02BE01

ATC

paracetamol; systemic, rectal

2.6

8.9

570

5118

J01CA04

ATC

amoxicillin; systemic

1.9

8.9

503

4311

P01AB01

ATC

metronidazole; oral, rectal

1.7

8.9

272

1973

M25.5

ICD-10 Finland

Pain in joint

1.7

8.8

229

1588

N02BF02

ATC

pregabalin; oral

2.5

8.8

248

Z50.1

ICD-10 Finland

Other physical therapy

2.7

8.8

193

A03

ICPC

Fever

2.0

8.8

107

588

L84

ICD-10 Finland

Corns and callosities

3.1

8.8

125

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

8.8

107

589

J01FA09

ATC

clarithromycin; systemic

1.7

8.8

206

1390

S20.2

ICD-10 Finland

Contusion of thorax

2.9

8.7

153

WZA00

NOMESCO Finland

Concise certificate

2.6

8.7

206

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

7.8

8.7

N03AX14

ATC

levetiracetam; systemic

3.8

8.7

L99

ICPC

Musculoskeletal disease other

4.1

8.7

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.7

8.6

S22.4

ICD-10 Finland

Multiple fractures of ribs

4.9

8.6

H26.02

ICD-10 Finland

Presenil cataract

3.6

8.6

WZA10

NOMESCO Finland

Extensive medical or dental certificate

6.5

8.5

A10AC01

ATC

insulin (human); parenteral

2.5

8.5

239

W10

ICD-10 Finland

Fall on and from stairs and steps

2.7

8.5

179

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

6.9

8.4

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

8.0

8.4

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.0

8.4

J01CF05

ATC

flucloxacillin; systemic

2.5

8.4

241

U07

ICPC

Urine symptom/complaint other

2.2

8.4

367

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

3.7

8.4

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

+∞

8.3

H26.4

ICD-10 Finland

After-cataract

2.0

8.3

524

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

8.7

8.3

I50.0

ICD-10 Finland

Congestive heart failure

2.3

8.3

300

R03AK11

ATC

formoterol and fluticasone; inhalant

3.6

8.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.6

8.3

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

4.2

8.3

S52.0

ICD-10 Finland

Fracture of upper end of ulna

4.2

8.3

RS220, ,

NOMESCO Finland

7.2

8.3

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

7.2

8.3

J01FA10

ATC

azithromycin; systemic

1.6

8.3

352

2758

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

8.3

144

889

R06AX22

ATC

ebastine; oral

1.9

8.2

118

685

R01AD09

ATC

mometasone; nasal

1.6

8.2

284

2111

SPAT1301

SPAT

No procedures

1.7

8.2

215

1490

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.5

8.2

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.8

8.2

153

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

4.8

8.2

TKC22

NOMESCO Finland

Catheterisation instruction

4.1

8.1

J04AB02

ATC

rifampicin; systemic

7.0

8.1

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

11.9

8.1

M30.0

ICD-10 Finland

Polyarteritis nodosa

33.8

8.1

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

33.8

8.1

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.1

8.1

457

M06

ICD-10 Finland

Other rheumatoid arthritis

9.1

8.1

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

8.1

239

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

8.1

291

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

8.1

247

1779

JN4CD

NOMESCO Finland

Very extensive body CT

3.1

8.0

115

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.0

8.0

126

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.0

8.0

126

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.9

8.0

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.3

8.0

305

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

8.0

331

2566

D68.8

ICD-10 Finland

Other specified coagulation defects

7.4

8.0

ZZH31

NOMESCO Finland

Bone allograft, small pieces

7.4

8.0

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

4.4

8.0

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.2

8.0

105

K99

ICPC

Cardiovascular disease other

3.7

7.9

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.9

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

7.9

216

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

13.2

7.9

R4180

NOMESCO Finland

Podiatric therapy

6.2

7.9

R4130

NOMESCO Finland

Speech therapy

3.6

7.9

WX204

NOMESCO Finland

Axillary plexus blockaced

3.1

7.9

111

J01EA01

ATC

trimethoprim; systemic

1.7

7.9

191

1293

K51.5

ICD-10 Finland

Left sided colitis

3.9

7.9

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.3

7.9

301

C08DA01

ATC

verapamil; systemic

2.7

7.9

168

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.7

7.9

168

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.7

7.8

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.2

7.8

B82

ICPC

Anaemia other/unspecified

3.2

7.8

SFA30

NOMESCO Finland

Three-surface restoration

1.6

7.8

270

2002

D86.0

ICD-10 Finland

Sarcoidosis of lung

6.5

7.8

N06AX11

ATC

mirtazapine; oral

1.6

7.8

232

1657

RS221, ,

NOMESCO Finland

6.0

7.7

K59.0

ICD-10 Finland

Constipation

2.4

7.7

231

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

45.6

7.7

C01CA24

ATC

epinephrine; parenteral

2.5

7.7

200

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

7.7

173

1146

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.6

7.7

L84

ICPC

Back syndrome without radiat pain

2.6

7.7

182

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.4

7.7

232

L20

ICPC

Joint symptom/complaint NOS

2.9

7.7

124

ZXA05

NOMESCO Finland

Left side

1.7

7.7

176

1173

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

7.6

207

C08CA05

ATC

nifedipine; systemic

2.5

7.6

207

M01AH01

ATC

celecoxib; oral

1.8

7.6

134

827

R03BA08

ATC

ciclesonide; inhalant

2.2

7.6

325

WX730

NOMESCO Finland

Conventional respirator

6.8

7.6

L04AA11

ATC

[U] etanercept

18.6

7.6

R5130, ,

SPAT

18.6

7.6

S22.1

ICD-10 Finland

Multiple fractures of thoracic spine

18.6

7.6

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

18.6

7.6

E23.03

ICD-10 Finland

Lack of ACTH

18.6

7.6

A02BA03

ATC

famotidine; systemic

2.9

7.6

130

EB1WA, ,

NOMESCO Finland

12.0

7.6

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

6.3

7.6

E000001, ,

ATC

1.8

7.6

130

797

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

7.6

354

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

7.6

361

J01DC02

ATC

cefuroxime; systemic

2.7

7.5

154

A29

ICPC

General symptom/complaint other

1.9

7.5

106

611

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

7.5

172

D02AE01

ATC

carbamide; topical

2.4

7.4

216

105

Kela drug reimbursment

Adrenal cortical hypofunction

81.0

7.4

207

Kela drug reimbursment

Chronic arrhythmias

1.8

7.4

124

754

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

13.6

7.4

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.0

7.4

110

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

7.4

146

933

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

7.3

127

ZX112

NOMESCO Finland

Subcutaneous

3.6

7.3

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

7.0

7.3

XF640, ,

NOMESCO Finland

3.3

7.3

R01AD05

ATC

budesonide; nasal

2.3

7.3

263

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

7.3

415

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

11.0

7.3

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

4.2

7.3

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.4

7.3

SBA00

NOMESCO Finland

Microbiological examinations

3.4

7.3

L04AK01

ATC

leflunomide; oral

9.5

7.3

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

7.3

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.8

7.3

139

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.8

7.2

128

JAH00

NOMESCO Finland

Laparotomy

3.2

7.2

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

4.6

7.2

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.3

7.2

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.7

7.2

140

R33

ICD-10 Finland

Retention of urine

2.3

7.2

252

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.4

7.2

207

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

30.4

7.2

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

30.4

7.2

M01AB55

ATC

diclofenac, combinations; oral

2.2

7.2

279

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

20.3

7.1

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

20.3

7.1

D68.9

ICD-10 Finland

Coagulation defect, unspecified

20.3

7.1

L04AC07

ATC

tocilizumab; parenteral

20.3

7.1

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.8

7.1

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

7.1

179

1218

S81.0

ICD-10 Finland

Open wound of knee

4.1

7.1

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.1

7.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

7.1

189

H02AB08

ATC

triamcinolone; systemic

12.2

7.1

3AC01, ,

NOMESCO Finland

8.9

7.1

L04AB06

ATC

golimumab; parenteral

10.2

7.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

7.1

244

1796

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

7.0

193

1342

R1250

NOMESCO Finland

Evaluation of functional capability

3.3

7.0

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.5

7.0

M81.5

ICD-10 Finland

Idiopathic osteoporosis

6.4

7.0

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.2

7.0

282

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.9

7.0

R96

ICPC

Asthma

2.0

6.9

423

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.2

6.9

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.1

6.9

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

6.9

276

D07AC01

ATC

betamethasone; topical

1.6

6.9

235

1720

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

6.9

409

R05

ICD-10 Finland

Cough

1.7

6.9

150

981

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

14.0

6.9

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

14.0

6.9

SPAT1260

SPAT

Consultation of another employee

1.8

6.9

120

737

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.3

6.9

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

6.9

127

794

M03BX01

ATC

baclofen; systemic

3.9

6.9

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.8

6.9

132

JF1AD

NOMESCO Finland

Small bowel CT

8.4

6.9

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

8.4

6.9

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

11.1

6.8

-1, ,

NOMESCO Finland

1.6

6.8

195

1370

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

6.8

182

1257

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

40.5

6.8

SPAT1210

SPAT

Application of cast or individual aid

2.7

6.7

139

S70

ICPC

Herpes zoster

3.1

6.7

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

7.3

6.7

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.0

6.7

105

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

6.7

328

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3.1

6.7

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

22.8

6.7

ZY010

NOMESCO Finland

Hospital outpatient

2.7

6.7

134

L50.8

ICD-10 Finland

Other urticaria

4.1

6.7

T99

ICPC

Endocr/metab/nutrit disease other

4.1

6.7

SFA10

NOMESCO Finland

One-surface restoration

1.6

6.6

325

2578

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.0

6.6

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.0

6.6

SPAT1310

SPAT

Counselling related to known health issue

1.6

6.6

204

1457

SFA20

NOMESCO Finland

Two-surface restoration

1.6

6.6

339

2717

N86

ICPC

Multiple sclerosis

12.4

6.6

S41.1

ICD-10 Finland

Open wound of upper arm

12.4

6.6

M04AA01

ATC

allopurinol; systemic

1.9

6.6

490

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.2

6.6

XX9XE

NOMESCO Finland

Other ultrasound examination

8.8

6.6

1XC02, ,

NOMESCO Finland

8.8

6.6

R99

ICPC

Respiratory disease other

3.9

6.6

L16

ICPC

Ankle symptom/complaint

1.9

6.6

483

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

10.2

6.6

N04BC05

ATC

pramipexole; oral

2.1

6.6

310

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

7.0

6.5

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

7.0

6.5

R35

ICD-10 Finland

Polyuria

2.2

6.5

249

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

6.5

290

A03FA02

ATC

cisapride; oral, rectal

2.1

6.5

290

J01DA06

ATC

[U] cefuroxime

1.8

6.5

576

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.4

6.5

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

6.3

6.5

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.6

6.5

148

N05BA01

ATC

diazepam; systemic, rectal

1.9

6.5

546

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

4.0

6.5

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

4.0

6.5

SPAT1104

SPAT

Monitoring of emergency patient

2.3

6.5

217

S01EE01

ATC

latanoprost; ophthalmic

2.2

6.5

257

R04.0

ICD-10 Finland

Epistaxis

2.1

6.4

305

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

6.4

224

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.3

6.4

211

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

7.5

6.4

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

7.5

6.4

B37.7

ICD-10 Finland

Candidal sepsis

70.6

6.4

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

6.4

152

1015

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

6.4

125

L01AA01

ATC

cyclophosphamide; systemic

14.5

6.4

B07.9

ICD-10 Finland

Verruca simplex

3.0

6.4

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

4.1

6.4

H20.1

ICD-10 Finland

Chronic iridocyclitis

6.7

6.4

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.7

6.4

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

8.3

6.4

NC1BA

NOMESCO Finland

Elbow extensive X-ray examination

8.3

6.4

QDA10

NOMESCO Finland

Incision of skin of lower limb

8.3

6.4

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.5

6.3

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.5

6.3

156

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

11.2

6.3

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

11.2

6.3

M35.1

ICD-10 Finland

Other overlap syndromes

11.2

6.3

XF404

NOMESCO Finland

Ambulatory ECG

2.0

6.3

336

I77.6

ICD-10 Finland

Arteritis, unspecified

18.2

6.3

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.3

6.3

207

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

6.3

M08.8

ICD-10 Finland

Other juvenile arthritis

+∞

6.3

E000002, ,

ATC

2.0

6.3

351

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.3

6.3

227

NDL52

NOMESCO Finland

Tenosynovectomy of hand

7.1

6.2

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

27.0

6.2

Z94.2

ICD-10 Finland

Lung transplant status

27.0

6.2

R52.0

ICD-10 Finland

Acute pain

2.9

6.2

104

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.9

6.2

104

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

6.2

104

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.2

6.2

Z71.8

ICD-10 Finland

Other specified counselling

1.6

6.2

210

1528

N03AX11

ATC

topiramate; oral

3.6

6.2

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.8

6.2

110

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.0

6.2

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

4.0

6.2

B37.08

ICD-10 Finland

Other candidal stomatitis

6.4

6.2

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

6.2

154

1041

C01AA05

ATC

digoxin; systemic

2.1

6.2

296

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.8

6.2

G35

ICD-10 Finland

Multiple sclerosis

5.8

6.2

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

6.1

441

M01CB03

ATC

auranofin; oral

7.8

6.1

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

7.8

6.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

6.1

276

S19

ICPC

Skin injury other

2.7

6.1

128

A02BX02

ATC

sucralfate; oral

2.7

6.1

128

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.1

6.1

D09

ICPC

Nausea

2.6

6.1

134

J01.1

ICD-10 Finland

Acute frontal sinusitis

4.2

6.1

D64.8

ICD-10 Finland

Other specified anaemias

4.2

6.1

C08CA01

ATC

amlodipine; oral

1.5

6.1

269

2073

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

6.1

263

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

6.1

273

2111

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

12.7

6.1

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

8.7

6.1

TJF80

NOMESCO Finland

Ostomy education

6.8

6.1

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

6.8

6.1

Y96.9

ICD-10 Finland

Unspecified type of accident

3.5

6.1

NHG20

NOMESCO Finland

Fusion of talocrural joint

10.2

6.0

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

3.4

6.0

Z51.5

ICD-10 Finland

Palliative care

2.0

6.0

370

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

6.0

313

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.1

6.0

ZX120, ,

SPAT

5.6

6.0

J32.4

ICD-10 Finland

Chronic pansinusitis

5.6

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020630) Protein [Mass/volume] in Serum or Plasma

259

549

7.42

127.93

2.0

3.2

64.08

66.87

g/l

5.65

231

501

(3003458) Phosphate [Moles/volume] in Serum or Plasma

303

805

6.45

116.92

7.6

5.1

1.03

1.05

mmol/l

0.26

282

731

(3004588) Protein electrophoresis panel - Serum or Plasma

231

487

7.00

113.22

1.8

2.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

225

468

7.00

111.63

5.4

3.1

9.19

10.54

g/l

3.40

219

429

(3036481) Cortisol [Moles/volume] in Serum or Plasma

246

582

6.38

106.22

3.2

2.1

270.00

382.15

nmol/l

8.41

235

538

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

542

2746

9.20

92.91

6.1

2.5

87.84

79.86

nmol/l

9.77

516

2432

(42870588) Differential panel, method unspecified - Blood

452

1965

5.91

92.27

18.4

6.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

182

379

6.40

88.38

2.7

1.9

1.13

1.27

g/l

0.52

172

342

(3019069) Monocytes/Leukocytes in Blood

529

2699

7.87

87.41

21.3

6.5

8.85

0.00

515

2516

(3042936) Bacteria identified in Isolate by Culture

280

860

5.14

87.13

3.5

2.0

—

(3022096) Basophils/Leukocytes in Blood

526

2689

7.61

86.11

21.4

6.5

0.63

0.69

1.99

511

2498

(3006504) Eosinophils/Leukocytes in Blood

526

2695

7.58

85.70

21.0

6.4

2.33

2.83

6.72

510

2508

(3023368) Bacteria identified in Blood by Culture

400

1643

5.10

85.59

8.9

4.3

—

(3018010) Neutrophils/Leukocytes in Blood

524

2693

7.39

84.52

19.9

6.4

62.86

57.56

18.07

514

2554

(3001604) Monocytes [#/volume] in Blood

546

2921

8.75

83.85

20.0

6.3

0.64

0.58

e9/l

6.85

517

2476

(3002030) Lymphocytes/Leukocytes in Blood

527

2738

7.46

83.44

20.9

6.5

22.92

27.30

16.94

515

2578

(3006315) Basophils [#/volume] in Blood

546

2935

8.67

82.96

20.0

6.3

0.04

e9/l

0.15

516

2489

(3019198) Lymphocytes [#/volume] in Blood

548

2973

8.74

81.86

20.3

6.4

1.69

1.90

e9/l

2.17

524

2583

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

243

696

5.12

81.61

4.8

4.3

251.00

250.75

u/l

0.01

228

655

(3013115) Eosinophils [#/volume] in Blood

551

3013

8.96

81.31

20.9

6.6

0.16

0.19

e9/l

3.76

521

2598

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

561

3137

9.98

80.24

18.4

6.9

1.22

mmol/l

0.19

500

2716

(3002179) Metamyelocytes/Leukocytes in Blood

202

505

5.47

79.53

8.2

4.7

0.62

0.57

0.17

100

158

(3034860) Kappa light chains.free [Mass/volume] in Serum

133

230

7.10

77.09

2.0

4.3

65.74

71.75

mg/l

0.05

103

199

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

133

230

7.10

77.09

2.0

4.3

28.88

42.52

mg/l

0.75

102

199

(3013650) Neutrophils [#/volume] in Blood by Automated count

563

3267

9.55

73.99

24.8

10.0

4.91

4.09

e9/l

12.10

542

2835

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

295

1048

4.49

73.92

3.3

1.9

—

(3017181) Myelocytes/Leukocytes in Blood

202

536

5.12

73.56

8.4

4.7

0.83

0.95

0.32

102

175

(3027945) Reticulocytes/Erythrocytes in Blood

240

737

4.70

72.73

3.5

2.8

2.13

1.84

1.37

217

662

(3021440) Promyelocytes/Leukocytes in Blood

193

501

5.16

72.01

8.5

4.9

0.06

0.12

0.60

139

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

198

529

5.05

71.28

3.9

3.7

79.41

83.92

ng/l

0.28

175

456

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

124

218

6.87

70.45

1.6

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

120

210

6.86

68.39

2.0

4.2

1.42

2.92

ratio

1.86

124

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

361

1562

4.17

67.16

4.1

2.4

3.76

3.06

mg/l

4.69

329

1337

(3023520) Reticulocytes [#/volume] in Blood

204

583

4.74

67.12

3.9

2.7

75.44

71.21

e9/l

0.79

152

433

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

180

466

5.05

66.93

2.7

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

509

2855

5.54

65.16

16.8

6.2

1.22

1.21

mmol/l

0.18

493

2624

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

108

183

6.95

63.30

2.6

1.7

0.23

g/l

0.14

102

174

(3025159) Blasts/Leukocytes in Blood

186

516

4.73

63.16

9.2

5.1

0.03

0.15

0.92

133

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

106

177

7.03

62.99

1.8

1.5

0.19

0.10

iu/ml

0.31

(3037522) Nuclear Ab [Titer] in Serum

239

803

4.23

62.94

1.9

1.4

708.11

517.89

titre

0.74

190

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

256

909

4.11

62.29

3.7

2.4

20.58

21.95

0.57

242

854

(3022948) Iron [Moles/volume] in Serum or Plasma

275

1038

3.98

61.08

3.8

2.4

10.55

12.49

umol/l

3.83

261

964

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

124

251

5.94

60.62

2.7

1.8

1.73

2.86

ug/l

0.43

112

220

(3004789) Transferrin [Mass/volume] in Serum or Plasma

263

968

4.00

60.49

3.7

2.4

2.24

2.30

g/l

1.05

247

897

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

148

355

5.17

59.77

6.6

3.6

2.42

1.90

mmol/l

0.90

119

276

(3012095) Magnesium [Moles/volume] in Serum or Plasma

266

997

3.94

59.39

7.0

3.2

0.80

0.81

mmol/l

1.16

255

935

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

113

8.34

59.07

10.3

5.0

314.38

426.64

iu/ml

0.17

(3024561) Albumin [Mass/volume] in Serum or Plasma

486

2745

4.67

58.56

11.2

4.8

33.06

35.48

g/l

16.82

462

2575

(3009343) pH of Capillary blood

158

407

4.88

58.47

7.3

3.6

7.42

0.36

140

340

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

129

282

5.52

57.84

1.8

1.9

1.67

1.56

g/l

0.47

111

248

(3007164) IgA [Mass/volume] in Serum or Plasma

288

1158

3.80

57.58

2.5

1.6

2.62

2.50

g/l

0.20

216

663

(3007853) Bacteria identified in Skin by Aerobe culture

207

674

4.12

56.09

3.1

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

9.39

55.60

2.0

2.1

0.69

0.91

g/l

0.43

(3020779) Urea [Moles/volume] in Serum or Plasma

176

514

4.40

55.23

12.9

6.2

10.78

9.75

mmol/l

0.62

171

491

(3023420) DNA double strand Ab [Units/volume] in Serum

122

273

5.33

53.04

2.6

2.0

7.43

7.48

iu/ml

0.01

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

224

803

3.81

52.37

2.8

1.8

—

(4062490) Immunoglobulin typing, IgG

12.55

50.44

1.9

1.3

—

(3035715) Granulocytes [#/volume] in Blood

8.14

50.19

6.0

3.6

4.32

4.52

e9/l

0.23

(3018418) pH of Serum or Plasma

376

1913

3.48

49.90

9.0

4.0

7.40

0.56

320

1372

(3024139) IgG subclass 3 [Mass/volume] in Serum

12.57

49.53

1.8

1.3

0.35

0.39

g/l

0.29

(3027135) IgG subclass 1 [Mass/volume] in Serum

12.57

49.53

1.8

1.3

6.58

7.42

g/l

0.37

(3028192) IgG subclass 2 [Mass/volume] in Serum

12.57

49.53

1.8

1.3

2.23

2.66

g/l

0.74

(3010838) Calcium [Moles/time] in 24 hour Urine

109

7.58

48.99

1.6

1.9

4.10

4.77

mmol/24h

0.89

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

163

6.30

48.98

2.7

1.5

—

(3026782) Osmolality of Urine

272

1168

3.38

47.08

4.9

3.0

474.96

514.43

mosm/kgh2o

2.66

249

1027

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

10.63

46.00

2.1

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

200

5.57

45.95

3.1

2.6

—

(3032080) INR in Blood by Coagulation assay

470

2835

3.79

45.67

28.2

15.5

1.28

1.26

inr

0.30

410

2348

(3037756) Immunofixation for Serum or Plasma

155

6.12

44.74

1.4

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

271

4.83

44.01

1.7

2.7

3.06

3.07

g/l

0.04

244

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

13.13

43.98

2.5

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

288

1325

3.21

43.69

1.5

1.3

0.85

1.42

u/ml

1.05

331

(3023419) Bacteria identified in Sputum by Culture

8.15

43.60

3.6

2.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

496

3148

3.97

43.40

15.1

6.4

11.51

11.19

umol/l

0.14

483

2999

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

290

4.65

42.88

1.7

2.6

3.63

3.74

g/l

0.28

264

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

291

4.63

42.69

1.7

2.6

4.30

4.28

g/l

0.03

264

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

291

4.63

42.69

1.7

2.6

7.76

7.58

g/l

0.43

264

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

151

6.03

42.63

2.1

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

171

579

3.71

42.49

3.8

2.3

0.21

g/l

0.01

164

541

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

171

5.68

42.27

1.3

1.6

—

(3035933) Granulocytes/Leukocytes in Blood

129

6.38

41.67

6.2

3.4

60.47

59.24

0.32

129

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

82.84

41.50

2.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

104

248

4.84

41.49

1.7

3.0

0.55

0.74

g/l

0.19

217

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

104

6.99

40.94

2.1

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

112

6.70

40.44

1.6

1.3

132.50

474.29

titre

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

171

5.46

39.16

6.4

2.6

0.32

0.41

iu/ml

1.25

101

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

195

756

3.31

38.75

2.9

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

351

1897

2.98

38.60

4.2

2.4

55.63

63.29

u/l

1.19

332

1742

(3001122) Ferritin [Mass/volume] in Serum or Plasma

423

2553

3.10

37.61

5.2

3.0

138.14

119.52

ug/l

0.83

402

2346

(3000494) Fungus identified in Specimen by Culture

189

731

3.29

37.56

2.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

154

5.57

37.49

2.1

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

383

2200

2.96

37.10

4.5

3.5

2.33

2.36

mmol/l

5.22

353

1978

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

165

593

3.44

36.88

1.9

1.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

7.09

36.80

4.0

3.7

1.70

1.66

0.02

(3031040) Bacteria [#/volume] in Urine by Automated count

540

3804

4.44

36.54

10.8

5.2

2800.83

3059.37

e6/l

—

(3017732) Neutrophils [#/volume] in Blood

188

739

3.22

36.20

5.0

3.0

5.06

4.80

e9/l

0.24

159

622

(46235355) HIV 1 and 2 tests - Meaningful Use set

174

656

3.30

35.89

2.0

1.6

—

(3037121) Protein [Mass/volume] in Urine

201

4.88

35.87

3.2

3.5

304.67

280.31

mg/l

0.08

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

100

259

4.42

35.76

1.5

2.7

9.04

10.36

g/l

1.59

231

(3026493) Urate [Moles/volume] in Serum or Plasma

292

1483

2.84

35.18

4.5

2.8

335.58

341.44

umol/l

0.38

260

1276

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

358

2025

2.84

34.97

6.0

3.3

1683.35

1207.14

ng/l

2.02

325

1731

(3017143) Hepatitis C virus Ab [Presence] in Serum

148

515

3.47

34.62

1.8

1.4

—

(3042631) Mycobacterium sp identified in Specimen

7.07

33.71

3.2

2.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

340

1899

2.77

33.61

3.9

2.2

97.13

199.27

u/l

6.58

323

1799

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

581

4407

6.76

33.56

27.6

8.2

78.67

79.95

u/l

0.30

572

4145

(3044640) Blood type and Crossmatch panel - Blood

337

1885

2.74

33.04

4.7

2.4

—

(3045424) Erythrocytes [Presence] in Urine

108

314

3.96

32.92

3.5

2.1

0.00

0.01

estimate

0.49

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

212

4.55

32.65

3.6

1.8

155.56

254.75

ug/l

1.50

199

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

5.42

32.47

2.0

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

135

5.45

32.25

1.9

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

499

3458

3.35

31.98

13.6

4.9

6.42

6.69

mmol/l

3.10

492

3305

(3000850) Epithelial cells [#/volume] in Urine

269

1362

2.73

31.86

5.3

2.7

5.33

5.82

e6/l

0.35

256

1253

(1616796) Gas panel - Central venous blood

111

5.88

31.63

5.6

4.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

245

1192

2.75

31.27

14.3

5.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

6.19

31.24

1.8

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

5.63

31.15

2.0

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

168

4.87

31.04

2.0

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

110

339

3.73

30.73

1.5

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

560

4216

4.67

30.55

17.2

4.7

18.56

13.25

mm/h

10.58

551

3905

(3022313) Gas panel - Capillary blood

102

302

3.85

30.18

8.8

3.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

214

4.33

29.66

1.6

2.7

0.02

g/l

0.08

196

(3006571) Granulocytes/Leukocytes in Synovial fluid

7.45

29.62

2.0

1.7

62.76

63.34

0.03

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

104

316

3.76

29.62

2.1

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

246

4.06

28.96

3.4

2.2

38.29

40.33

u/l

0.34

219

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

136

5.14

28.96

1.8

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

115

380

3.49

28.82

2.3

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

450

3030

2.81

28.71

8.2

4.3

0.00

estimate

-0.00

146

630

(3030467) Casts [#/volume] in Urine by Automated count

300

1665

2.57

28.68

7.0

3.4

0.38

0.45

e6/l

0.32

258

1230

(3019309) Folate [Moles/volume] in Red Blood Cells

227

1105

2.67

28.44

2.1

1.8

1237.07

1213.67

nmol/l

0.13

177

807

(3002582) Erythrocytes [#/volume] in Urine

331

1931

2.55

28.36

7.1

3.5

34.25

79.72

e6/l

0.69

287

1494

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

213

4.23

28.16

1.4

2.7

0.00

g/l

-0.00

188

(3035350) Ketones [Presence] in Urine by Test strip

451

3060

2.78

27.98

8.1

4.3

0.00

5.43

estimate

0.80

148

645

(3019225) pH of Specimen

153

610

3.01

27.97

10.2

4.1

7.38

7.36

1.40

140

433

(3009261) Glucose [Presence] in Urine by Test strip

455

3101

2.80

27.97

8.1

4.3

0.00

0.51

estimate

0.53

147

617

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

157

4.75

27.88

3.3

2.1

9.87

12.64

mg/l

1.79

148

(3044927) Protein electrophoresis panel - Urine

6.36

27.24

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

7.25

27.04

3.3

3.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

117

5.27

26.79

1.9

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

217

4.09

26.64

3.5

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

266

1434

2.51

26.55

4.4

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

218

4.07

26.47

1.5

1.2

—

(3003181) Sodium [Moles/volume] in Urine

141

4.78

25.85

1.7

1.3

61.70

62.65

mmol/l

0.05

116

(3018095) Leukocytes [#/volume] in Urine

352

2173

2.45

25.82

8.7

4.2

77.17

115.22

e6/l

0.81

289

1562

(3005322) IgE [Units/volume] in Serum or Plasma

109

373

3.34

25.68

1.8

1.2

178.13

208.80

u/ml

0.18

104

345

(3009214) Lutropin [Units/volume] in Serum or Plasma

5.64

25.55

1.4

17.18

10.80

u/l

0.96

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

247

1305

2.49

25.54

2.7

1.7

1.88

1.31

mg/l

1.03

207

1036

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

205

4.09

25.47

3.2

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

6.00

24.15

2.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

6.00

24.15

2.3

1.7

—

(3019977) pH of Arterial blood

163

722

2.71

24.11

12.8

6.7

7.43

7.42

0.98

414

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

168

4.28

23.86

1.4

1.2

12.80

7.23

u/ml

—

(3027801) Oxygen [Partial pressure] in Arterial blood

163

726

2.69

23.81

12.7

6.6

11.30

12.07

kpa

0.83

157

706

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

163

726

2.69

23.81

12.7

6.6

5.14

5.10

kpa

0.21

156

705

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

144

602

2.82

23.79

6.2

3.5

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

6.80

23.72

1.1

1.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

398

2656

2.41

23.64

5.1

2.7

—

estimate

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

193

937

2.54

23.61

3.7

1.9

30.09

29.02

1.50

185

904

(3021960) Folate [Moles/volume] in Serum or Plasma

310

1862

2.34

23.48

2.2

1.7

21.18

20.87

nmol/l

0.13

267

1543

(3003396) Base excess in Arterial blood by calculation

160

715

2.67

23.15

13.1

6.7

1.72

1.09

mmol/l

1.00

138

601

(3012501) Base excess in Blood by calculation

108

5.06

23.09

6.3

3.8

2.76

2.60

mmol/l

0.15

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

197

3.94

22.83

1.5

2.8

0.00

g/l

-0.00

187

(3006184) Hemoglobin [Mass/volume] in Capillary blood

147

4.41

22.77

3.2

2.4

120.02

125.91

g/l

0.96

117

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

6.77

22.42

1.8

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

7.14

22.28

1.9

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

147

645

2.68

21.95

6.5

2.7

12.49

7.95

umol/l

0.80

133

574

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

5.11

21.65

1.4

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

200

3.82

21.57

1.5

1.2

5.37

2.49

u/ml

0.59

(3000475) Leukocytes [#/volume] in Synovial fluid

158

4.18

21.52

2.4

1.6

29962.58

17438.60

e6/l

0.45

106

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

201

3.80

21.42

1.4

1.3

19.37

3.09

u/ml

1.05

(3014576) Chloride [Moles/volume] in Serum or Plasma

175

846

2.49

21.31

15.2

6.3

102.82

103.96

mmol/l

1.99

175

846

(3000991) Gas panel - Venous blood

128

536

2.75

20.86

18.3

7.4

—

(3015736) pH of Urine

367

2445

2.24

20.73

6.2

3.8

6.27

6.26

0.08

175

1345

(36660697) Celiac disease serology panel - Serum

116

465

2.84

20.52

1.2

—

(3045414) Leukocytes [Presence] in Urine

137

600

2.65

20.40

3.4

2.2

0.00

0.03

estimate

0.50

119

(3014148) Varicella zoster virus Ab [Titer] in Serum

6.52

19.92

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

287

1754

2.19

19.86

8.8

4.4

0.00

estimate

0.50

141

590

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

195

1025

2.32

19.43

1.5

1.3

29.41

12.62

u/ml

1.41

368

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

190

3.71

19.35

1.8

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

7.47

19.22

2.3

1.5

27.66

34.08

0.36

(3021589) Normoblasts [#/volume] in Blood

365

2484

2.15

18.79

39.0

12.1

0.00

e9/l

0.09

333

2028

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

6.31

18.75

1.3

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

6.31

18.75

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

6.31

18.75

1.3

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

5.94

18.71

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

5.26

18.32

3.9

3.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

5.48

18.17

1.3

1.1

4.85

3.72

u/ml

0.24

(40768797) Stomach Pathology biopsy report

170

864

2.34

18.15

1.3

1.2

—

(3003129) Base excess in Capillary blood by calculation

5.56

17.98

4.2

1.9

1.07

0.57

mmol/l

0.28

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

349

2364

2.10

17.82

8.7

4.0

124.21

73.53

ng/l

0.24

307

1789

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.48

17.69

1.3

1.1

1.46

1.50

u/ml

0.04

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

117

4.27

17.43

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

117

4.27

17.43

1.4

—

(3012544) pH of Venous blood

139

657

2.44

17.41

8.6

3.8

7.38

0.68

372

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

7.10

17.09

2.2

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

462

3515

2.26

17.05

7.3

3.2

80.40

47.42

u/l

2.81

437

3249

(3017446) Testosterone [Moles/volume] in Serum or Plasma

283

3.06

16.98

2.5

2.4

10.75

13.27

nmol/l

1.88

257

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

6.47

16.87

1.1

1.2

0.13

1.78

u/ml

0.89

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

199

1113

2.16

16.63

1.5

1.3

55.98

35.85

iu/ml

0.66

351

(21494814) CD8 cells/Lymphocytes in Specimen

18.56

16.59

2.1

1.4

29.00

32.21

0.21

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

384

2743

2.06

16.41

2.7

2.2

96.35

96.54

pmol/l

0.02

218

1346

(3048689) Calprotectin [Mass/mass] in Stool

145

719

2.33

16.19

5.0

2.5

165.34

133.68

ug/g

0.77

123

564

(3041096) Erythrocytes [Presence] in Urine by Automated

254

1572

2.05

16.11

7.3

3.7

0.16

0.05

estimate

0.28

129

507

(3002032) Base excess in Venous blood by calculation

132

633

2.38

15.89

9.1

3.8

2.72

1.90

mmol/l

1.59

115

551

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

6.82

15.86

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

6.23

15.71

2.2

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

4.59

15.65

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

6.42

15.58

2.2

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

15.27

15.47

4.5

1.7

0.58

0.60

mmol/l

0.71

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

133

3.83

15.39

1.7

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

134

659

2.32

15.17

8.9

3.8

5.96

5.81

kpa

0.60

129

637

(3000012) Reticulocyte production index

4.36

15.06

5.6

2.0

1.17

0.87

1.53

(3044941) Cell count panel - Synovial fluid

112

4.05

15.01

1.8

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

4.32

14.86

1.3

274.43

291.05

u/ml

0.11

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

283

1859

1.97

14.84

8.2

3.0

30.82

31.11

u/l

0.06

276

1753

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

5.21

14.45

1.2

57.32

57.71

u/l

0.01

(40758558) Short blood count panel - Blood

271

1771

1.95

14.27

15.5

6.5

—

(3017704) Immunofixation for Urine

6.60

14.19

1.3

1.7

—

(40761536) Microorganisms panel - Urine sediment

437

2.51

14.19

7.7

4.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

146

3.56

14.13

1.6

1.2

71.67

112.14

titre

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

5.38

14.03

2.2

1.8

—

(3022145) Colonoscopy Study observation

137

701

2.23

14.01

1.7

1.3

—

(3000492) Spirometry study

105

487

2.39

13.48

2.3

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

168

945

2.07

13.41

6.1

3.2

2.69

3.00

e6/l

0.19

102

451

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

4.31

13.39

1.9

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

4.38

13.33

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

103

476

2.40

13.32

5.3

3.4

178.06

217.59

ng/l

0.69

442

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

4.94

13.20

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

4.26

13.19

1.9

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

4.26

13.19

1.9

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

4.33

13.12

2.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

4.33

13.12

2.0

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

129

3.60

13.00

1.3

—

(3004451) EKG impression Narrative

5.77

12.98

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

345

2.59

12.94

2.4

3.2

4.09

4.45

pmol/l

2.29

302

(3005988) Vibrio sp identified in Specimen by Organism specific culture

4.28

12.92

2.0

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

155

3.35

12.89

3.6

3.3

2.41

1.94

index

0.17

(4268621) Lupus anticoagulant assay

5.50

12.87

2.4

2.1

—

(3042733) HLA Ab [Presence] in Serum

32.79

12.62

2.4

3.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

4.71

12.48

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

11.96

12.40

3.7

6.1

—

(3012441) Differential panel - Pleural fluid

5.08

12.26

1.5

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

5.39

12.10

1.5

1.1

113.79

108.61

pmol/l

0.15

(3037692) Legionella sp identified in Specimen by Organism specific culture

10.34

12.08

1.5

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

212

1337

1.89

11.95

3.6

2.9

2.47

mmol/l

0.18

195

1202

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

9.20

11.84

1.4

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

9.20

11.84

1.4

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

9.20

11.84

1.4

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

9.20

11.84

1.4

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

329

2.53

11.75

18.8

7.9

14.82

15.59

1.66

319

(44806118) Parainfluenza type 4 nucleic acid detection

4.33

11.65

2.3

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

4.33

11.65

2.3

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

4.33

11.65

2.3

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

4.33

11.65

2.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

383

2918

1.83

11.51

3.7

2.7

—

(3025941) Bacteria identified in Stool by Culture

302

2.57

11.41

1.5

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

205

1296

1.87

11.36

1.9

1.7

485.57

16508994.86

pmol/l

0.74

173

1054

(40768804) Tissue Pathology biopsy report

319

2307

1.80

11.35

2.8

2.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

5.27

11.34

1.3

1.2

233.33

140.00

titre

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

13.03

11.20

2.1

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

108

548

2.18

11.10

4.1

2.4

35.23

33.92

u/l

0.14

448

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

10.84

1.4

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

10.84

1.4

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

4.18

10.79

2.1

2.3

1.20

1.11

g/24h

0.06

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

590

5310

3.73

10.77

64.3

17.2

23.60

24.01

mg/l

0.14

578

4396

(40768443) Skin Pathology biopsy report

280

2.56

10.69

1.4

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

172

1048

1.89

10.58

5.9

3.0

0.91

1.08

e6/l

0.46

107

554

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

10.29

10.57

1.4

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

3.61

10.31

1.4

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

5.41

10.17

3.4

2.6

43.21

40.98

0.18

(40768806) Pleura Pathology biopsy report

4.50

9.88

1.5

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

3.90

9.88

1.6

1.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

4.82

9.84

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

411

2.24

9.79

8.6

3.5

119.49

126.90

g/l

2.44

400

(40759836) Histone Ab [Presence] in Serum by Immunoblot

4.56

9.62

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

4.56

9.62

1.7

1.4

352309.18

350966.66

e6/l

0.00

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

4.72

9.60

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

5.27

9.41

2.3

1.5

15.58

16.51

0.60

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

4.62

9.37

1.3

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

306

2278

1.68

9.10

8.4

4.3

0.01

0.03

estimate

0.85

128

513

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

139

3.01

9.03

1.0

1.1

—

8.54

—

(3003327) Ova and parasites identified in Stool by Light microscopy

191

2.70

8.98

1.7

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

113

3.22

8.93

1.9

1.6

—

(40768441) Liver Pathology biopsy report

4.44

8.93

2.7

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

4.44

8.93

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

4.44

8.93

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

520

2.05

8.88

3.1

2.5

8.76

6.57

ug/l

0.36

454

(4035726) Immunohistochemistry procedure

102

550

2.02

8.84

2.1

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

4.23

8.79

1.3

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

510

4399

1.93

8.69

5.7

4.6

15.41

15.01

pmol/l

2.86

475

3989

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.05

8.67

1.4

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

103

562

2.00

8.63

9.3

3.5

4.86

4.40

kpa

1.43

543

(3008295) Osmolality of Serum or Plasma

3.62

8.61

1.3

1.4

269.24

273.11

mosm/kgh2o

0.37

(4195642) Thrombophilia screening test

4.15

8.59

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

16.57

8.58

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

16.57

8.58

2.4

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

162

2.78

8.41

3.7

3.8

0.89

0.85

nmol/l

0.20

134

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

179

1174

1.74

8.36

7.8

4.3

624.16

333.29

ng/l

0.30

155

950

(3024471) HLA-A [Type]

14.72

8.23

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

4.01

8.22

1.7

1.2

1446.12

1799.76

e6/l

0.32

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

4.01

8.22

3.5

2.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

200

2.58

8.20

1.7

1.4

292.14

297.59

ug/g

0.09

120

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.23

8.05

1.6

1.3

8653.33

54843.20

e6/l

0.88

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

4.36

7.99

1.1

103.55

99.81

0.23

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

3.80

7.97

1.1

1.64

1.49

g/l

1.09

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

155

2.76

7.97

1.6

1.2

39.60

42.21

u/ml

—

(3028433) Virus identified in Specimen by Culture

8.61

7.85

1.1

—

(3045142) Bone marrow Pathology biopsy report

3.58

7.62

1.5

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

109

3.04

7.50

1.5

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

492

1.97

7.47

2.1

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

4.10

7.40

1.6

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

134

2.79

7.22

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

112

2.96

7.16

1.5

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

6.15

7.12

2.3

2.2

—

(3047181) Lactate [Moles/volume] in Blood

159

2.62

7.08

7.6

6.1

1.26

1.28

mmol/l

0.05

142

(21494890) Protein electrophoresis panel - 24 hour Urine

3.43

6.89

1.3

2.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

3.11

6.85

2.2

2.6

35.91

23.72

mg/l

0.72

(3000060) B lymphocytes [#/volume] in Blood

9.46

6.81

2.5

0.19

0.29

e9/l

—

(3009508) Creatinine [Moles/volume] in Urine

275

2098

1.56

6.72

4.4

3.4

5.79

6.83

mmol/l

4.04

244

1747

(3024932) HLA-DR beta [Type]

12.42

6.60

1.0

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

6.29

6.50

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

102

2.93

6.45

1.5

1.3

156.57

152.53

au/ml

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

557

5069

2.05

6.45

7.2

5.8

1.90

1.96

mu/l

0.51

526

4623

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.81

6.41

1.7

1.2

—

(3045788) Cell count panel - Pleural fluid

3.81

6.41

1.7

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

258

2.20

6.40

2.4

3.2

459.34

1062.58

u/ml

0.45

223

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

3.42

6.33

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.67

6.08

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

110

688

1.73

5.90

3.2

4.1

5.26

16.15

ug/l

1.05

569

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.96

5.77

1.0

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.96

5.77

1.0

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.53

5.77

1.8

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

8.59

5.57

1.1

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

7.18

5.46

1.8

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

16.19

5.42

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.27

5.42

1.3

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

3.35

5.34

2.0

1.5

—

(3024263) Appearance of Synovial fluid

5.48

5.25

3.6

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

587

5515

2.41

5.21

62.8

20.7

138.80

139.68

mmol/l

9.90

581

5411

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.86

5.20

1.1

1.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

587

5520

2.39

5.11

63.2

20.9

3.95

3.98

mmol/l

1.62

581

5409

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

10.13

5.04

1.8

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

10.13

5.04

1.8

2.2

—

(3011436) Histone Ab [Units/volume] in Serum

10.13

5.04

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

148

2.37

5.03

1.9

1.7

3.13

43.76

iu/l

0.52

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

130

2.46

4.97

3.8

3.7

146.88

2784.12

u/ml

0.78

125

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.73

4.95

1.5

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

470

1.76

4.75

3.3

2.7

55.87

63.28

ml/min/173m2

0.78

208

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.70

4.71

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

4.75

4.70

1.1

—

(3048879) Bone marrow aspiration report

8.28

4.57

1.4

2.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

10.11

4.53

2.0

1.5

47.12

39.00

umol/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

162

2.23

4.52

1.2

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

555

5157

1.78

4.40

51.2

17.1

75.18

76.21

ml/min/173m2

0.51

539

4812

(40761539) Cells [Type] in Urine sediment by Light microscopy

7.59

4.36

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

589

5587

2.28

4.30

37.1

12.9

25.64

24.17

u/l

1.03

584

5410

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.99

4.29

1.3

1.1

102.00

106.00

—

(40757373) Influenza virus identified in Isolate

8.99

4.29

2.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.92

4.22

1.7

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.92

4.22

1.7

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.32

4.21

1.7

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.32

4.21

1.7

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.87

4.20

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

5.31

4.16

1.0

1.1

10.67

9.33

ug/l

0.30

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.07

4.12

1.2

1.0

—

(21494434) Karyotype in Bone marrow

2.99

4.04

1.1

—

(3011648) Oxygen content in Venous blood

2.99

4.04

2.6

6.4

10.42

10.51

0.03

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

113

782

1.55

3.99

4.5

5.2

35.83

32.98

1.72

481

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

315

1.82

3.98

2.4

2.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

4.13

3.92

1.0

1.1

315.54

296.59

mg/l

0.47

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

152

2.17

3.91

2.1

1.3

1438.22

511.12

mg/l

0.60

145

(3013637) Mi-2 Ab [Presence] in Serum

4.85

3.88

1.3

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.85

3.88

1.3

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.85

3.88

1.3

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.85

3.88

1.3

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.02

3.87

1.4

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

7.35

3.87

1.0

—

(3034426) Prothrombin time (PT)

7.35

3.87

1.1

1.2

27.12

27.00

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

135

2.20

3.73

1.2

1.3

—

(3002256) Pathology report gross observation

108

751

1.53

3.73

1.3

—

(3014271) Vancomycin [Susceptibility]

3.65

3.72

3.5

2.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.88

3.71

1.4

1.0

—

(4015189) Microbial culture of sputum

6.74

3.68

2.4

4.2

—

(40768446) Kidney Pathology biopsy report

5.69

3.67

1.6

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

4.46

3.63

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

498

1.62

3.62

2.5

1.7

1.55

1.51

0.22

431

(3006442) Creatine [Moles/volume] in Serum or Plasma

4.06

3.61

2.6

1.3

89.92

76.03

umol/l

0.37

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.85

3.56

1.3

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

2.86

3.54

5.5

2.8

13.30

13.14

index

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.29

3.52

2.0

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.29

3.52

1.1

1.0

1579.27

1552.50

miu/ml

0.03

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

6.22

3.51

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

10.08

3.50

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.13

3.41

1.2

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.13

3.41

1.2

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.13

3.41

1.4

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

7.06

3.37

1.3

3.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

7.06

3.37

1.4

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.69

3.30

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

8.64

3.27

1.3

1.4

—

(3013727) Leukocytes other/Leukocytes in Blood

4.79

3.25

5.3

3.8

54.44

51.37

—

(3044290) Cell count panel - Cerebral spinal fluid

110

2.23

3.23

2.3

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

4.22

3.20

1.0

1.2

713.80

113.02

iu/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.39

3.20

1.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.42

3.19

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

6.42

3.19

1.3

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.00

3.15

1.9

1.3

—

(3047189) Immunofixation for 24 hour Urine

3.48

3.12

1.2

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.71

3.10

1.7

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.71

3.10

1.7

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

7.56

3.06

1.2

1.0

1.21

1.19

mmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

161

1.97

3.05

1.5

1.4

32.83

27.69

iu/l

0.25

133

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.59

3.00

1.2

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

10.07

2.98

1.4

—

(3018572) Chloride [Moles/volume] in Blood

114

2.15

2.98

9.8

6.4

104.58

104.93

mmol/l

0.16

105

(3039000) Anion gap in Blood by calculation

114

2.15

2.98

9.8

6.4

10.25

10.97

mmol/l

0.83

105

(3010813) Leukocytes [#/volume] in Blood

592

5698

2.04

2.95

83.5

26.5

7.76

6.68

e9/l

19.39

584

5558

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.75

2.92

1.0

1.6

75.00

66.00

nmol/24h

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.75

2.89

1.3

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

6.72

2.87

1.0

1.1

—

(1002224) Polysomnography panel

236

0.37

2.86

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.80

2.83

1.2

0.64

1.19

nmol/l

—

(3005570) Glucose [Moles/volume] in Urine

2.68

2.81

1.5

2.8

—

(3019174) dRVVT (LA screen)

8.39

2.75

1.0

1.3

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

591

5697

1.96

2.74

83.1

26.4

92.92

91.40

10.13

586

5632

(3007461) Platelets [#/volume] in Blood

591

5698

1.95

2.72

83.6

26.5

261.05

250.54

e9/l

2.58

585

5582

(3035941) MCH [Entitic mass]

591

5698

1.95

2.72

82.9

26.4

30.34

30.31

0.16

586

5632

(3026361) Erythrocytes [#/volume] in Blood

591

5698

1.95

2.72

83.3

26.5

4.14

4.41

e12/l

30.59

585

5560

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

591

5698

1.95

2.72

85.7

26.9

37.62

39.80

16.70

586

5630

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.18

2.65

2.8

3.2

0.73

1.06

0.49

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

109

813

1.41

2.63

1.4

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.71

2.60

1.3

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.19

2.55

1.2

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

7.19

2.55

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.63

2.54

1.5

—

53.33

—

(3022621) pH of Urine by Test strip

468

1.51

2.48

5.2

2.8

6.33

6.10

1.31

315

(3032057) Clostridioides difficile [Presence] in Stool

4.41

2.48

2.3

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

243

1.69

2.44

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

2.44

0.0

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

6.29

2.37

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

2.48

2.29

1.5

—

538.00

—

(3033799) Differential panel - Peritoneal fluid

3.92

2.25

6.4

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

540

5129

1.43

2.25

7.7

7.0

39.27

39.68

mmol/mol

0.50

493

4761

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

5.59

2.21

1.0

—

(3051651) Icteric interference index of Serum or Plasma

2.89

2.21

6.2

2.9

0.70

0.83

index

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

129

1.90

2.20

2.3

1.4

3.67

121.25

e6/l

1.09

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.53

2.19

1.2

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

3.36

2.18

1.3

2.0

37.88

41.64

g/l

—

(21494755) Public health laboratory ask at order entry panel

331

0.50

2.17

1.2

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.71

2.15

2.0

2.6

2.43

6.73

ug/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

2.13

2.14

1.6

1.3

445.75

259.88

pmol/l

1.37

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

5.03

2.07

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.53

2.06

2.4

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.36

1.97

1.1

1.7

69.00

137.23

umol/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

127

1.84

1.96

2.4

1.4

11.50

6.16

e6/l

0.27

(3049717) Cytology report of Urine Cyto stain

219

1.63

1.95

2.6

2.8

—

(3024869) Neuronal Ab [Presence] in Serum

4.57

1.94

1.0

1.1

—

(4024509) Urine culture

300

1.54

1.94

2.4

2.2

—

(40768795) Lymph node Pathology biopsy report

2.18

1.89

1.8

1.2

—

(40765096) Chromosome analysis panel by Banding

3.21

1.88

1.1

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.19

1.82

1.0

1.1

0.02

u/ml

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.19

1.79

2.2

2.7

1478.23

671.15

0.69

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

153

0.39

1.78

1.2

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.36

1.75

1.3

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.36

1.75

1.3

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.36

1.75

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

125

1.79

1.74

7.2

3.8

29.29

28.75

mg/l

0.04

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.16

1.72

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.18

1.66

1.3

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

362

1.45

1.66

1.2

26.51

142.92

u/ml

7.35

141

(3001019) Free T4 and TSH panel - Serum or Plasma

211

0.47

1.65

1.1

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

128

1.75

1.62

3.5

1.2

0.87

0.90

g/l

0.20

128

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.59

1.62

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.59

1.62

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.35

1.59

1.8

1.2

8.53

6.38

ug/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.29

1.56

1.3

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

236

2086

1.21

1.53

4.8

4.1

24.40

7.29

mg/mmol

1.78

148

1243

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.87

1.51

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.87

1.51

1.2

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

545

5250

1.33

1.48

5.8

5.6

5.61

5.98

mmol/l

11.69

492

4767

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

179

1.59

1.48

1.3

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.24

1.47

2.3

1.8

100.85

96.33

ng/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

527

0.68

1.45

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.52

1.45

1.3

1.6

120.71

173.92

mmol/24h

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

180

1.58

1.45

1.3

1.1

—

(1761868) Lipid panel - Serum or Plasma

162

1876

0.81

1.45

3.2

3.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

457

4320

1.23

1.41

66.2

21.8

14.93

13.77

35.62

457

4271

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

2.19

1.40

1.6

1.4

0.12

0.20

nmol/l

—

(3003694) ABO and Rh group [Type] in Blood

165

1418

1.22

1.40

1.4

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

183

1.56

1.37

1.3

1.2

—

(3008898) HLA-B27 [Presence]

184

1.55

1.34

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.37

1.29

1.8

2.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.79

1.28

1.6

1.3

0.38

0.27

g/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.79

1.28

1.4

1.1

—

(3023410) Appearance of Cerebral spinal fluid

1.89

1.18

3.2

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

544

5275

1.27

1.11

5.6

5.5

4.64

4.65

mmol/l

0.09

494

4843

(3044007) Cell count panel - Peritoneal fluid

2.39

1.09

2.8

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.96

1.09

2.0

1.7

6.37

8.00

mmol/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.28

1.03

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

540

5242

1.25

1.02

5.5

5.4

1.60

1.52

mmol/l

2.96

490

4782

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.01

1.00

1.7

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

1.63

0.94

1.3

—

(40768793) Breast Pathology biopsy report

195

0.61

0.92

1.2

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.15

0.91

1.2

1.0

—

(3012516) Albumin [Mass/volume] in Urine

224

2046

1.15

0.90

4.2

3.4

77.87

35.62

mg/l

1.43

148

1243

(3028300) Cannabinoids [Presence] in Urine

1.59

0.88

1.3

—

(3027008) Opiates [Presence] in Urine

1.59

0.88

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

550

5370

1.23

0.83

6.1

6.4

2.56

2.67

mmol/l

2.04

504

4915

(3028707) Methadone [Presence] in Urine by Screen method

1.68

0.74

1.2

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

202

1.35

0.74

2.3

1.4

0.37

0.33

mg/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.57

0.69

1.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.65

0.69

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.65

0.69

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

127

1.43

0.68

1.7

1.8

—

(3027944) Amphetamines [Presence] in Urine

1.50

0.67

1.4

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

516

5031

1.16

0.66

4.9

4.6

1.34

1.27

mmol/l

1.69

461

4538

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.58

0.65

2.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

176

0.68

0.62

7.0

2.0

7.39

2.72

mg/l

0.54

141

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

147

1.37

0.62

1.6

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

129

1169

1.13

0.59

6.0

5.8

2.11

2.41

ug/l

0.20

110

1042

(3002523) Influenza virus A Ag [Presence] in Specimen

1.52

0.56

1.4

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.54

0.53

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.48

0.51

1.1

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.53

0.48

7.3

2.3

69.00

34.29

mg/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

148

1.29

0.44

5.5

4.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.2

—

2.13

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

115

1.31

0.39

1.3

1.5

1.16

0.87

nmol/l

0.86

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

312

0.83

0.39

2.0

1.9

—

(3016879) Cocaine [Presence] in Urine

1.36

0.38

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.38

0.34

1.4

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.28

0.32

1.3

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

743

0.90

0.30

12.1

7.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

252

1.16

0.27

1.4

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

181

0.82

0.25

1.7

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

159

0.81

0.25

1.4

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

939

0.93

0.25

4.4

4.9

20.10

21.65

0.36

471

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

231

2384

0.95

0.23

1.9

2.0

1.52

1.31

mmol/l

2.00

198

1972

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

1.73

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

31.76

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

29.14

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.21

0.0

1.4

—

(4133840) Spirometry

0.00

0.21

0.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

1.16

0.21

2.6

2.2

2.62

2.19

ug/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.21

0.0

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.21

0.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.74

0.17

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

399

1.08

0.16

1.1

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

285

0.91

0.14

1.9

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

276

1.09

0.14

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

891

0.96

0.11

1.6

1.4

—

(4034850) Laboratory test

184

1.09

0.09

22.8

11.3

—

(3019150) Specific gravity of Urine by Refractometry

140

1370

1.03

0.09

9.4

4.6

1.01

1.02

kg/l

2.02

102

918

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

704

0.96

0.08

2.9

3.2

0.48

0.77

ug/l

4.49

459

(3025130) Human papilloma virus identified in Specimen

1.06

0.08

1.3

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.05

0.07

1.0

1.3

—

(4281824) Cell count and differential, peritoneal fluid

1.06

0.07

1.7

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.13

0.07

1.1

1.3

0.60

21.39

nmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

386

0.96

0.06

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

131

0.91

0.05

2.8

2.5

325.80

106.85

ug/min

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.88

0.00

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.4

—

6.92

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

287.18

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

48.00

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.7

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

7.53

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint OSTPOPATFRACTURE and mortality.

Females

Parameter	HR [95% CI]	p-value
OSTPOPATFRACTURE	2.879 [2.39, 3.46]	< 0.001
Birth year	0.996 [0.99, 1.01]	0.421

During the follow-up period (1.1.1998 — 31.12.2019), 572 out of 1455 females with OSTPOPATFRACTURE died.

Males

Parameter	HR [95% CI]	p-value
OSTPOPATFRACTURE	4.177 [3.06, 5.7]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.09

During the follow-up period (1.1.1998 — 31.12.2019), 329 out of 649 males with OSTPOPATFRACTURE died.

Mortality risk

Mortality risk for people of age

years, who have OSTPOPATFRACTURE.

N-year risk	Females	Males
1	0.297%	0.753%
5	1.672%	4.626%
10	3.99%	12.785%
15	7.552%	23.481%
20	14.115%	37.703%

Relationships between endpoints

↥

Index endpoint: OSTPOPATFRACTURE – Drug-induced osteoporosis with pathological fracture

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced osteoporosis with pathological fracture

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints